- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01270529
Pedometers to Assess and Increase Physical Activity Among Children With Chronic Kidney Disease
Hypothesis #1: Most children with CKD stages 2-4, ESRD and kidney transplantation will report participation in physical activity that falls short of recommended levels of physical activity; Children on dialysis will be less active.
Hypothesis #2: Patients will endorse many barriers to physical activity, some of which will be related to their disease or its treatment; those who are less active will endorse more barriers.
Hypothesis #3: Patients will increase their participation in physical activity in response to a pedometer-based 12 week intervention.
Baseline level of physical activity and magnitude of increase in physical activity will be more closely associated with change in physical functioning and performance than stage of kidney disease or type of renal replacement therapy.
Exercise capacity of the child will be measured by the six minute walk test whereby the subject will asked to walk as far as possible in 6 minutes in a straight corridor.
Body fat or body composition will then be measured by Bioelectric Impedance Spectroscopy.
Physical functioning or Health Related Quality of Life will be assessed self reported/ parent proxy reliable and validated questionnaire specifically designed for child with chronic kidney disease called Pediatric Quality of Life Inventory (Peds QL 4.0). Subjects (teens) or parents will also be asked to fill out a questionnaire on barriers to physical activity on their first visit.
Physical activity will be measured in the form of daily steps. The child will wear the pedometer for the first week to assess his/her baseline level of activity. Then the child will continue to wear the pedometer for another 12 weeks during which time he or she will be asked to gradually increase steps walked per day above baseline physical activity. The patient will be called once a week in order to monitor progress, set new weekly step goals (usually 500-1000 steps/day greater than the previous week), and motivate the participant.
After 12 weeks of the pedometer-based intervention to increase physical activity, physical performance, body composition and physical functioning (as described above) will be measured once again to assess the effect of increased physical activity on a second visit.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
California
-
San Francisco, California, Stati Uniti, 94122
- UCSF
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Pediatric patients, male and female, aged 6-20 years.
- Chronic kidney disease stages 2-4 and ESRD on peritoneal dialysis or hemodialysis and kidney transplantation.
- Patients who can follow simple commands.
- English and Spanish speaking only.
Exclusion Criteria:
- Patients hospitalized in the past 1 month.
- Patients hospitalized in the past I month for infection.
- Patients hospitalized in the past 1 month post peritoneal or hemodialysis catheter placement for the first time.
- 1 month after starting renal replacement therapy for the first time.
- 3 months post kidney transplantation.
- In the opinion of the investigator too ill to participate.
- Unwilling to participate.
- Language barrier.
- Patient with any signs of active infection, shortness of breath, trauma or injury to the legs or feet or those undergoing cardiac evaluation.
- Patients unable to verbalize discomfort or developmental delay will not be included.
- Patients with respiratory distress or on oxygen will be excluded.
- Parents or subjects unable to afford transportation for the 2 scheduled visits will also be excluded.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Non randomizzato
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: CKD Stages 1-4
|
The subjects (CKD Stages 1-4, ESRD on Hemodialysis or Peritoneal Dialysis) will continue to wear the pedometer for 12 weeks during which time he or she will be asked to gradually increase steps walked per day above baseline physical activity.
The patient will be called once a week in order to monitor progress, set new weekly step goals (usually 500-1000 steps/day greater than the previous week), and also to motivate the participant.
|
|
Sperimentale: ESRD on Dialysis
|
The subjects (CKD Stages 1-4, ESRD on Hemodialysis or Peritoneal Dialysis) will continue to wear the pedometer for 12 weeks during which time he or she will be asked to gradually increase steps walked per day above baseline physical activity.
The patient will be called once a week in order to monitor progress, set new weekly step goals (usually 500-1000 steps/day greater than the previous week), and also to motivate the participant.
|
|
Sperimentale: Kidney Transplant recipients
|
The subjects (CKD Stages 1-4, ESRD on Hemodialysis or Peritoneal Dialysis) will continue to wear the pedometer for 12 weeks during which time he or she will be asked to gradually increase steps walked per day above baseline physical activity.
The patient will be called once a week in order to monitor progress, set new weekly step goals (usually 500-1000 steps/day greater than the previous week), and also to motivate the participant.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Physical Activity
Lasso di tempo: Baseline, 12 weeks
|
Participants will measure physical activity in the form of daily steps using a pedometer
|
Baseline, 12 weeks
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 10-03869
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Malattia renale cronica
-
Zhen LiIscrizione su invitoTrapianto simultaneo di pancreas-kidneyCina
-
University Hospital, Basel, SwitzerlandNon ancora reclutamentoSindrome cardiovascolare-kidney-metabolica | Sindrome cradiovascolare-kidney-metabolica (CKLM)Svizzera
-
Chung Shan Medical UniversityNational Science and Technology Council, TaiwanNon ancora reclutamentoObesità Diabete mellito di tipo 2 | Malattia epatica steatotica associata a disfunzione metabolica | Sindrome cardiovascolare-kidney-metabolicaTaiwan
-
CHU de ReimsNon ancora reclutamentoReattività fluida nel periodo di trapianto post-kidney precoceFrancia
-
Third Affiliated Hospital, Sun Yat-Sen UniversityAttivo, non reclutanteInsufficienza epatica acuta su Chronic (ACLF)Cina
-
Camille N. Kotton, MDKamada, Ltd.; University of Texas Southwestern Medical CenterReclutamentoCitomegalovirus | Trapianto renale; Complicazioni | Trapianto d'organo | Complicanze del trapianto di fegato | Trapianto simultaneo di fegato-kidney; ComplicazioniStati Uniti
-
Yaqrit LtdKing's College Hospital NHS Trust; University College, London; Royal Free Hospital... e altri collaboratoriNon ancora reclutamentoCirrosi epatica | Insufficienza epatica acuta su Chronic (ACLF)
-
Nanjing Medical UniversityNon ancora reclutamentoSindrome cardiovascolare-kidney-metabolica
-
Institute of Liver and Biliary Sciences, IndiaNon ancora reclutamentoInsufficienza epatica acuta su Chronic (ACLF)
-
Institute of Liver and Biliary Sciences, IndiaNon ancora reclutamentoInsufficienza epatica acuta su Chronic (ACLF)
Prove cliniche su Increasing Physical activity
-
Istanbul Kültür UniversityMarmara University; Istanbul University - Cerrahpasa (IUC)CompletatoAttività fisica | Morbo di Parkinson | Bilancia | Cadente | KinesiofobiaTacchino
-
Rabin Medical CenterTerminatoDiabete di tipo 1Israele
-
University Hospital, ToulouseAttivo, non reclutante
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); University of Rochester; University of Massachusetts...CompletatoCancro al seno | Sopravvissuto al cancro al seno | Tracker per il fitnessStati Uniti
-
Maastricht University Medical CenterSt. Antonius Hospital; Gelderse Vallei Hospital; ild care foundationCompletatoFatica | Sarcoidosi
-
prof dr Pieter GillardUniversity Colleges Leuven LimburgCompletato
-
University of BariProf. Maria GranoCompletato
-
Universiteit AntwerpenUniversity Hospital, Antwerp; Cliniques universitaires Saint-Luc- Université...CompletatoEmofilia A | Emofilia BBelgio
-
Stony Brook UniversityAttivo, non reclutanteAttività fisicaStati Uniti
-
Istituto Auxologico ItalianoReclutamentoComportamento sanitarioItalia